Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PMCB

PharmaCyte Biotech, Inc.

CIK 0001157075 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$0.53
↑ 0.02 (3.64%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$5.72M
P/E Ratio
-0.29
EPS
-2.77
Dividend Yield
Not covered
52W Position
3%
Beta
1.61

Valuation multiples

Fwd P/E
7.02
PEG
0.00
P/B
0.17
P/S
Not covered
EV/Revenue
Not covered
ROE
-58.3%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 3%
$0.50$1.51

Latest Financials

2026-04-30 FY
Revenue
$0.00
Net Income
-$19.42M
Total Assets
$46.75M
Free Cash Flow
–

Recent news